Cholesterol-lowing therapy with simvastatin improves brachial endothelium-dependent relaxation

JieQi Li,Shuiping Zhao,Xiangping Li

1998-01-01

Abstract:Objective: To investigate the effect of cholesterol-lowering therapy with simvastatin on endothelium-dependent relaxing function in patients with hypercholesterolemia. Methods: With high-resolution ultrasound, we measured endothelium-dependent relaxing function in 50 subjects: 25 of them with normal blood cholesterol and the others with established primary hypercholesterolemia. Results: In patients with primary hypercholesterolemia, flow-mediated dilatation in arteries was much reduced compared with control group (3.5% ± 2.8% vs 14.5% ± 3.4%, P < 0.001). However, there was no significant difference in response to nitroglycerin between the two groups (20.5% ± 7.2% vs 22.9% ± 4.3%, P = 0.49). Twenty-five hypercholesterolemic patients were studied before and after cholesterol-lowering therapy with simvastatin (an inhibitor of HMG-CoA reductase) for 3.8 ± 0.8 months, by which serum cholesterol lowered from 6.31 ± 0.70 mmol/L to 5.06 ± 0. 63 mmol/L (P < 0.001). Flow-mediated vasodilations were greater after simvastatin therapy than before (10.0 ± 3.2% vs 3.5 ± 2.8%, P < 0.001). The vasodilation response to nitroglycerin was no significant change after cholesterol-lowering therapy. Conclusion: Endothelium-dependent vasodilation was impaired in patients with primary hypercholesterolemia, and cholesterol- lowering therapy with simvastatin may improve impaired endothelium-dependent vasodilation.